ICD-10-CM Billable Code

F13.11

Sedative, hypnotic or anxiolytic abuse, in remission

Clinical Classification Guidelines

Inclusion Terms

  • Sedative, hypnotic or anxiolytic use disorder, mild, in early remission
  • Sedative, hypnotic or anxiolytic use disorder, mild, in sustained remission

Medical Intelligence & Overview

ICD-10 code F13.11 refers to individuals who previously experienced a disorder related to the misuse of sedatives, hypnotics, or anxiolytics but are currently in remission. These medications are often prescribed to manage anxiety, sleep issues, or related conditions. When misuse or abuse occurs, it can lead to health complications, but remission indicates that there has been a significant reduction or cessation of problematic use. This classification helps healthcare providers monitor and support individuals in maintaining their recovery journey.

Causes & Symptoms

Clinical Causes: Underlying mental health issues such as anxiety or insomnia leading to misuse of prescribed medications. Psychological dependence on sedatives or anxiolytics for relief from stress or sleep disturbances. Development of tolerance, prompting increased use or misuse. Environmental factors, including stressors or social influences promoting continued use despite potential risks. Lack of access to proper medical guidance or abrupt discontinuation leading to misuse patterns.

Key Symptoms: Previous patterns of excessive or inappropriate use of sedative, hypnotic, or anxiolytic medications. Signs of psychological dependence, such as cravings or strong desire to use the substance. Development of tolerance, requiring higher doses to achieve the same effect prior to remission. Potential episodes of relapse, characterized by resumed misuse or overuse of these medications. General health issues caused by prior misuse, including cognitive impairments, drowsiness, or coordination problems.

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a thorough clinical assessment by a healthcare professional. This includes reviewing medication history, evaluating the presence of any ongoing symptoms related to misuse, and ensuring the individual is currently in remission. Diagnostic criteria for substance use disorders include checking for patterns of use, dependence, and impact on daily functioning. Periodic monitoring helps ensure sustained remission.

Treatment Protocols: Counseling or psychotherapy, such as cognitive-behavioral therapy, to address underlying issues and develop coping strategies. Medication management to safely taper off or substitute medications if needed. Support groups or peer support networks that provide encouragement and accountability. Education about substance use and strategies to maintain sobriety. Regular follow-up appointments with healthcare providers to monitor mental health and medication use.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F13.11 a billable ICD-10 code?
Yes, F13.11 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F13.11?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse, in remission and any associated comorbidities for accurate reporting.

Cite this Clinical Reference